Lensar (LNSR) EBIT Margin (2019 - 2026)

Lensar's (LNSR) quarterly EBIT Margin came in at 16.67% in Q1 2026, up 5757.0% year-on-year from 0.28% in Q1 2025, and up 131.34% on a QoQ basis from 53.2% in Q4 2025.

Lensar (LNSR) EBIT Margin (2019 - 2026) Analysis & Trends

Lensar (LNSR) has 8 years of EBIT Margin data on file, last reported at 16.67% in Q1 2026.

  • On a quarterly basis, EBIT Margin rose 5757.0% year-over-year to 16.67% in Q1 2026; TTM through Mar 2026 was 34.68%, a 501.0% decrease from a year earlier, with the FY2025 full-year figure at 47.58%, down 2438.0% from the prior year.
  • EBIT Margin for Q1 2026 stood at 16.67%, up from 53.2% in the prior quarter.
  • Over the last five years, EBIT Margin for LNSR reached as high as 16.67% in Q1 2026 and fell as low as 982.76% in Q1 2024.
  • Historically, EBIT Margin has averaged 96.21% across 5 years, with a median of 49.42% in 2024.
  • Across the five-year window, EBIT Margin plunged 92991 bps in 2024 and surged 94187 bps in 2025, its largest moves.
  • Year by year, EBIT Margin stood at 30.37% in 2022, then grew by 7 bps to 28.2% in 2023, then soared by 50 bps to 14.02% in 2024, then tumbled by 279 bps to 53.2% in 2025, then jumped by 131 bps to 16.67% in 2026.
  • Per Business Quant data, the three most recent EBIT Margin figures were 16.67% in Q1 2026, 53.2% in Q4 2025, and 59.42% in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBIT Margin (Qtr)
1 Abbott Laboratories 201.40 Bn 194.75 Bn 6.27 Bn 12.05%
2 Stryker 122.29 Bn 119.41 Bn 3.81 Bn 15.55%
3 Medtronic 105.01 Bn 96.40 Bn 6.41 Bn 19.10%
4 Boston Scientific 64.81 Bn 63.59 Bn 3.61 Bn 21.16%
5 Edwards Lifesciences 55.28 Bn 51.60 Bn 1.29 Bn 28.97%
6 Dexcom 29.06 Bn 27.94 Bn 750.30 Mn 21.42%
7 Koninklijke Philips 29.02 Bn 25.93 Bn 2.07 Bn 6.17%
8 GE HealthCare Technologies 28.27 Bn 26.20 Bn 1.98 Bn 10.04%
9 Smith & Nephew 25.80 Bn 25.22 Bn - -
10 Lensar 70.05 Mn 72.73 Mn 6.38 Mn 16.67%

Historic Data

Download Data
DateValue
Mar 31, 2026 16.67%
Dec 31, 2025 -53.20%
Sep 30, 2025 -59.42%
Jun 30, 2025 -51.17%
Mar 31, 2025 -40.89%
Dec 31, 2024 -14.02%
Sep 30, 2024 -10.54%
Jun 30, 2024 -49.42%
Mar 31, 2024 -982.76%
Dec 31, 2023 -28.20%
Sep 30, 2023 -24.66%
Jun 30, 2023 -27.78%
Mar 31, 2023 -52.85%
Dec 31, 2022 -30.37%
Sep 30, 2022 -52.70%
Jun 30, 2022 -102.64%
Mar 31, 2022 -71.55%
Dec 31, 2021 -34.86%
Sep 30, 2021 -88.24%
Jun 30, 2021 -64.51%